Known drugs and small molecules in the battle for COVID-19 treatment
COVID-19 has been declared a pandemic by the World Health Organization on March 11th and since then more than 3 million cases and a quarter million deaths have occurred due to it. The urge to find a resultful treatment or cure is now pressing more than any other time since the outbreak of the pandem...
Main Author: | Alexios A. Panoutsopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2020-12-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304220300799 |
Similar Items
-
Comparison of Different Treatment Strategies Combating COVID-19 in Pakistan
by: Afsheen Mansoor, et al.
Published: (2022-11-01) -
The Efficacy of Famotidine in Improvement of Outcomes in Hospitalized COVID-19 Patients: A Phase III Randomized Clinical Trial
by: Hamid Reza Samimagham, et al.
Published: (2022-05-01) -
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein–Drug and Protein–Protein Structures: An Analysis of Kinetically Active Residues
by: Ognjen Perišić
Published: (2020-09-01) -
COVID-19 incidence, severity, medication use, and vaccination among dentists: survey during the second wave in Brazil
by: Rafael R MORAES, et al.
Published: (2022-10-01) -
Effect of Famotidine on COVID-19: Killing Virus or Opposing ARDS?
by: Mahnaz Sadat Hosseini, et al.
Published: (2023-04-01)